Polyamine Metabolism in Disease and Polyamine-Targeted Therapies

Polyamines are ubiquitous polycations essential for all cellular life. The most common polyamines in eukaryotes, spermine, spermidine, and putrescine, exist in millimolar intracellular concentrations that are tightly regulated through biosynthesis, catabolism, and transport. Polyamines interact with...

Full description

Saved in:
Bibliographic Details
:
Year of Publication:2019
Language:English
Physical Description:1 electronic resource (240 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 05608nam-a2201177z--4500
001 993548361504498
005 20231214133146.0
006 m o d
007 cr|mn|---annan
008 202102s2019 xx |||||o ||| 0|eng d
020 |a 3-03921-153-6 
035 |a (CKB)4100000010106147 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/56626 
035 |a (EXLCZ)994100000010106147 
041 0 |a eng 
100 1 |a Murray-Stewart, Tracy  |4 auth 
245 1 0 |a Polyamine Metabolism in Disease and Polyamine-Targeted Therapies 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2019 
300 |a 1 electronic resource (240 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Polyamines are ubiquitous polycations essential for all cellular life. The most common polyamines in eukaryotes, spermine, spermidine, and putrescine, exist in millimolar intracellular concentrations that are tightly regulated through biosynthesis, catabolism, and transport. Polyamines interact with, and regulate, negatively charged macromolecules, including nucleic acids, proteins, and ion channels. Accordingly, alterations in polyamine metabolism affect cellular proliferation and survival through changes in gene expression and transcription, translation, autophagy, oxidative stress, and apoptosis. Dysregulation of these multifaceted polyamine functions contribute to multiple disease processes, thus their metabolism and function have been targeted for preventive or therapeutic intervention. The correlation between elevated polyamine levels and cancer is well established, and ornithine decarboxylase, the rate-limiting biosynthetic enzyme in the production of putrescine, is a bona fide transcriptional target of the Myc oncogene. Furthermore, induced polyamine catabolism contributes to carcinogenesis that is associated with certain forms of chronic infection and/or inflammation through the production of reactive oxygen species. These and other characteristics specific to cancer cells have led to the development of polyamine-based agents and inhibitors aimed at exploiting the polyamine metabolic pathway for chemotherapeutic and chemopreventive benefit. In addition to cancer, polyamines are involved in the pathologies of neurodegenerative diseases including Alzheimer’s and Parkinson’s, parasitic and infectious diseases, wound healing, ischemia/reperfusion injuries, and certain age-related conditions, as polyamines are known to decrease with age. As in cancer, polyamine-based therapies for these conditions are an area of active investigation. With recent advances in immunotherapy, interest has increased regarding polyamine-associated modulation of immune responses, as well as potential immunoregulation of polyamine metabolism, the results of which could have relevance to multiple disease processes. The goal of this Special Issue of Medical Sciences is to present the most recent advances in polyamine research as it relates to health, disease, and/or therapy. 
546 |a English 
653 |a protein synthesis in cancer 
653 |a neuroblastoma 
653 |a epigenetics 
653 |a Drosophila imaginal discs 
653 |a pneumococcal pneumonia 
653 |a transgenic mice 
653 |a spermidine/spermine N1-acetyl transferase 
653 |a ?-difluoromethylornithine 
653 |a MYC 
653 |a skeletal muscle 
653 |a protein expression 
653 |a curcumin 
653 |a colorectal cancer 
653 |a autophagy 
653 |a human embryonic kidney 293 (HEK293) 
653 |a melanoma 
653 |a tumor immunity 
653 |a Snyder-Robinson Syndrome 
653 |a Streptococcus pneumoniae 
653 |a B-lymphocytes 
653 |a autoimmunity 
653 |a spermine oxidase 
653 |a cell differentiation 
653 |a diferuloylmethane 
653 |a immunity 
653 |a antizyme 
653 |a transgenic mouse 
653 |a polyamine 
653 |a hirsutism 
653 |a chemoprevention 
653 |a CRISPR 
653 |a transglutaminase 
653 |a polyamine analogs 
653 |a NF-?B 
653 |a spermine synthase 
653 |a atrophy 
653 |a aging 
653 |a oxidative stress 
653 |a mast cells 
653 |a African sleeping sickness 
653 |a pancreatic ductal adenocarcinoma 
653 |a eflornithine 
653 |a carcinogenesis 
653 |a ornithine decarboxylase 
653 |a polyamine transport inhibitor 
653 |a putrescine 
653 |a neutrophils 
653 |a spermidine 
653 |a untranslated region 
653 |a spermine 
653 |a polyphenol 
653 |a M2 macrophages 
653 |a polyamine transport system 
653 |a metabolism 
653 |a difluoromethylorthinine 
653 |a DFMO 
653 |a antizyme inhibitors 
653 |a capsule 
653 |a polyamine transport 
653 |a eosinophils 
653 |a MCF-7 cells 
653 |a difluoromethylornithine 
653 |a polyamine metabolism 
653 |a mutant BRAF 
653 |a polyamines 
653 |a cadaverine 
653 |a proteomics 
653 |a airway smooth muscle cells 
653 |a breast cancer 
653 |a X-linked intellectual disability 
653 |a complementation 
653 |a T-lymphocytes 
653 |a bis(ethyl)polyamine analogs 
653 |a antizyme 1 
653 |a cancer 
653 |a osteosarcoma 
776 |z 3-03921-152-8 
906 |a BOOK 
ADM |b 2024-02-27 23:13:06 Europe/Vienna  |f system  |c marc21  |a 2020-02-01 22:26:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338791010004498&Force_direct=true  |Z 5338791010004498  |b Available  |8 5338791010004498